Coldstream Capital Management Inc. Sells 40,410 Shares of Colgate-Palmolive Company $CL

Coldstream Capital Management Inc. lessened its stake in Colgate-Palmolive Company (NYSE:CL) by 73.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,396 shares of the company’s stock after selling 40,410 shares during the quarter. Coldstream Capital Management Inc.’s holdings in Colgate-Palmolive were worth $1,138,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of CL. Brighton Jones LLC lifted its holdings in shares of Colgate-Palmolive by 4.4% in the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after purchasing an additional 450 shares in the last quarter. Woodline Partners LP lifted its holdings in shares of Colgate-Palmolive by 76.3% in the first quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock valued at $4,344,000 after purchasing an additional 20,062 shares in the last quarter. Schnieders Capital Management LLC. lifted its holdings in shares of Colgate-Palmolive by 2.0% in the second quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company’s stock valued at $1,136,000 after purchasing an additional 245 shares in the last quarter. Nebula Research & Development LLC lifted its holdings in shares of Colgate-Palmolive by 165.5% in the second quarter. Nebula Research & Development LLC now owns 10,326 shares of the company’s stock valued at $939,000 after purchasing an additional 6,437 shares in the last quarter. Finally, Sei Investments Co. lifted its holdings in shares of Colgate-Palmolive by 21.7% in the second quarter. Sei Investments Co. now owns 657,093 shares of the company’s stock valued at $59,732,000 after purchasing an additional 116,968 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $90.16 on Wednesday. The company has a debt-to-equity ratio of 16.33, a current ratio of 1.02 and a quick ratio of 0.67. The business has a fifty day simple moving average of $86.19 and a two-hundred day simple moving average of $85.41. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $99.33. The company has a market capitalization of $72.34 billion, a P/E ratio of 35.08, a P/E/G ratio of 4.71 and a beta of 0.31.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.94 by $0.03. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.22 billion. During the same period last year, the business posted $0.91 earnings per share. The business’s revenue for the quarter was up 8.4% on a year-over-year basis. On average, analysts expect that Colgate-Palmolive Company will post 3.82 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, May 15th. Shareholders of record on Monday, April 20th were given a $0.53 dividend. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.52. This represents a $2.12 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date of this dividend was Monday, April 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is 82.49%.

Wall Street Analysts Forecast Growth

CL has been the topic of a number of recent research reports. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $99.00 target price on shares of Colgate-Palmolive in a report on Monday, May 4th. Barclays increased their price target on Colgate-Palmolive from $79.00 to $80.00 and gave the company an “equal weight” rating in a research report on Tuesday, May 5th. UBS Group increased their price target on Colgate-Palmolive from $98.00 to $100.00 and gave the company a “buy” rating in a research report on Monday, May 4th. Weiss Ratings raised Colgate-Palmolive from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday, May 4th. Finally, Rothschild & Co Redburn set a $100.00 price target on Colgate-Palmolive and gave the company a “buy” rating in a research report on Tuesday, April 21st. Twelve research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $95.88.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.